Nortriptyline is not an SSRI. It belongs to an older class of antidepressants called tricyclic antidepressants (TCAs), which work differently in the brain and carry a distinct side effect profile. The two drug classes are sometimes confused because both treat depression, but they are pharmacologically separate categories.
How Nortriptyline Actually Works
SSRIs, or selective serotonin reuptake inhibitors, do exactly what their name suggests: they selectively block the reabsorption of serotonin in the brain, leaving more of it available to improve mood. Common SSRIs include fluoxetine (Prozac), sertraline (Zoloft), and escitalopram (Lexapro).
Nortriptyline takes a broader approach. As a tricyclic antidepressant, it blocks the reabsorption of both norepinephrine and serotonin. It also interacts with several other receptor systems in the body, including histamine and acetylcholine receptors. That wider reach is why TCAs tend to cause more side effects than SSRIs, but it’s also why nortriptyline can be useful for conditions beyond depression, particularly pain-related ones.
What Nortriptyline Is Prescribed For
The FDA approved nortriptyline (sold under the brand name Pamelor) specifically for the relief of depression symptoms, with the label noting that endogenous depression is more likely to respond than other depressive states. In practice, though, nortriptyline is frequently prescribed off-label for a wide range of conditions: chronic pain, diabetic neuropathy, myofascial pain, trigeminal neuralgia, postherpetic neuralgia (nerve pain after shingles), migraine prevention, smoking cessation, and even persistent cough caused by nerve irritation.
This versatility in pain management is one of the key practical differences between nortriptyline and SSRIs. While SSRIs are sometimes used for chronic pain, tricyclics like nortriptyline have a longer track record for nerve-related pain conditions. If your doctor prescribed nortriptyline for pain rather than depression, that’s a common and well-established use.
Side Effects Compared to SSRIs
The side effect profiles of nortriptyline and SSRIs reflect how differently these drugs act in the body. Because nortriptyline affects acetylcholine receptors (something SSRIs largely don’t do), it tends to cause what are called anticholinergic side effects: dry mouth, constipation, blurred vision, and urinary retention. Drowsiness, tiredness, weight gain, low blood pressure, and a faster-than-normal heart rate are also associated with tricyclics like nortriptyline.
SSRIs, by contrast, are more commonly linked to nausea, headache, insomnia, diarrhea, fatigue, and weight loss. Sexual side effects are also well known with SSRIs.
Neither profile is universally “better.” Some people tolerate one class well and struggle with the other. The sedating quality of nortriptyline, for instance, can be a benefit for people who have trouble sleeping, while the activating tendency of some SSRIs suits people who feel sluggish with depression.
Dosing and Monitoring
One notable difference between nortriptyline and SSRIs is how dosing works. Nortriptyline has a defined therapeutic window, meaning there’s a specific range of drug levels in the blood where it works best. The standard starting dose for depression is typically 100 to 150 mg per day, but the relationship between the dose you swallow and the level that ends up in your blood varies enormously from person to person. This means your doctor may order blood tests to check your nortriptyline level. Levels that are too low won’t relieve symptoms, and levels that are too high can cause side effects without improving effectiveness.
SSRIs generally don’t require blood level monitoring. Doctors adjust the dose based on how you feel and what side effects you report, which makes them simpler to manage in routine practice. This is one reason SSRIs became the first-line treatment for depression starting in the late 1980s and remain so today.
Cardiovascular Safety
Heart-related risks are another area where nortriptyline and SSRIs diverge. Tricyclic antidepressants as a class carry a higher risk of cardiovascular complications than SSRIs, particularly in overdose. At normal prescribed doses, however, the picture is more nuanced. Research comparing nortriptyline to the SSRI paroxetine found that nortriptyline’s risk of sudden death or dangerous heart rhythm disturbances was no greater than paroxetine’s, a drug considered to have a very favorable cardiovascular profile.
That said, nortriptyline has been associated with a greater risk of cardiovascular events during regular clinical use compared to SSRIs. And in overdose, tricyclics are significantly more dangerous than SSRIs, which is one reason doctors tend to prescribe SSRIs first, especially for patients who may be at risk of self-harm. If you’re taking nortriptyline and have heart concerns, that’s worth discussing with your prescriber, but at standard doses the risk for most people is manageable.
Why the Confusion Exists
People often search for whether nortriptyline is an SSRI because both drug classes treat depression and both affect serotonin. The critical distinction is selectivity. SSRIs are designed to target serotonin alone, while nortriptyline acts on multiple neurotransmitter systems simultaneously. That broader mechanism is what makes nortriptyline a tricyclic antidepressant rather than an SSRI, and it’s what accounts for both the wider range of uses and the broader side effect profile.
If you’ve been switched from an SSRI to nortriptyline (or vice versa), the transition typically needs to be managed carefully because combining the two classes can push serotonin levels dangerously high. Your prescriber will usually taper one before starting the other.